Augmented Zika and Dengue Neutralizing Antibodies Are Associated With Guillain-Barre Syndrome

Fecha de publicación:

Autores organización

  • Alexandra Porras Ramirez

    Autor

Autores

  • Lynch, RM
  • Mantus, G
  • Encinales, L
  • Pacheco, N
  • Li, GZ
  • Mendoza, AR
  • Peng, J
  • Rengifo-Pardo, M
  • Cruz, MM
  • Harris, E
  • Bethony, JM
  • Simon, GL
  • Chang, AY

Grupos de investigación

Resumen

The role of neutralizing antibodies in Zika-induced Guillain-Barre syndrome (GBS) has not yet been investigated. We conducted a case-control study using sera from the 2016 Zika epidemic in Colombia to determine the neutralizing antibody activity against Zika virus (ZIKV) and dengue virus serotype 2 (DENV2). We observed increased neutralizing antibody titers against DENV2 in ZIKV-infected individuals compared with uninfected controls and higher titers to both ZIKV and DENV2 in ZIKV-infected patients diagnosed with GBS compared with non-GBS ZIKV-infected controls. These data suggest that high neutralizing antibody titers to DENV and to ZIKV are associated with GBS during ZIKV infection.

Datos de la publicación

ISSN/ISSNe:
0022-1899, 1537-6613

Journal Of Infectious Diseases  Oxford University Press

Tipo:
Article
Páginas:
26-30

Citas Recibidas en Web of Science: 15

Citas Recibidas en Scopus: 24

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Guillain-Barre syndrome; neutralizing antibody; flavivirus; Zika; dengue

Campos de estudio

Citar la publicación

Compartir la publicación